荣泰健康
(603579)
| 流通市值：45.02亿 | | | 总市值：45.02亿 |
| 流通股本：2.01亿 | | | 总股本：2.01亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 442,196,878.4 | 1,572,896,808.32 | 1,148,150,857.84 | 810,202,891.61 |
| 营业收入 | 442,196,878.4 | 1,572,896,808.32 | 1,148,150,857.84 | 810,202,891.61 |
| 二、营业总成本 | 421,907,631.52 | 1,519,345,912.84 | 1,091,080,657.84 | 751,180,423.4 |
| 营业成本 | 305,387,534.3 | 1,089,588,660.36 | 779,656,119.56 | 546,841,588.52 |
| 税金及附加 | 5,936,333.71 | 25,410,974.58 | 20,910,726.92 | 14,742,388.11 |
| 销售费用 | 59,849,135.76 | 205,919,558.08 | 142,912,857.47 | 93,630,050.8 |
| 管理费用 | 20,453,041.1 | 87,172,105.52 | 60,452,637.45 | 39,474,362.13 |
| 研发费用 | 25,953,507.35 | 93,303,153.4 | 70,139,092.89 | 44,021,424.86 |
| 财务费用 | 4,328,079.3 | 17,951,460.9 | 17,009,223.55 | 12,470,608.98 |
| 其中:利息费用 | 537,999.43 | 20,423,348.43 | 21,061,650.24 | 16,306,851.36 |
| 其中:利息收入 | 1,175,250.51 | 6,603,815.81 | 5,274,419.88 | 3,896,421.02 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -3,383,368.29 | 41,137,303.46 | 3,693,388.71 | 213,254.07 |
| 加:投资收益 | 41,251,966.37 | 64,570,599.22 | 44,991,588.97 | 29,957,204.55 |
| 资产处置收益 | -3,304.88 | 1,726,012.43 | 1,587,979.47 | 220,885.15 |
| 资产减值损失(新) | 342,707.25 | -5,454,946.82 | -2,027,423.58 | -1,707,794.53 |
| 信用减值损失(新) | -168,807.21 | 671,058.44 | -194,357.68 | 772,703.08 |
| 其他收益 | 9,228,355.63 | 27,728,399.57 | 23,814,822.16 | 19,703,572.16 |
| 四、营业利润 | 67,556,795.75 | 183,929,321.78 | 128,936,198.05 | 108,182,292.69 |
| 加:营业外收入 | 6,460.23 | 5,191,547.26 | 95,865.51 | 25,203.83 |
| 减:营业外支出 | 12,034 | 4,696,128.55 | -1,060,197.35 | -1,133,857.94 |
| 五、利润总额 | 67,551,221.98 | 184,424,740.49 | 130,092,260.91 | 109,341,354.46 |
| 减:所得税费用 | -1,632,459.09 | 34,428,989.91 | 19,223,774.68 | 23,793,094.39 |
| 六、净利润 | 69,183,681.07 | 149,995,750.58 | 110,868,486.23 | 85,548,260.07 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 69,183,681.07 | 149,995,750.58 | 110,868,486.23 | 85,548,260.07 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 69,738,811.66 | 150,702,547.22 | 110,821,738.73 | 85,336,914.36 |
| 少数股东损益 | -555,130.59 | -706,796.64 | 46,747.5 | 211,345.71 |
| 扣除非经常损益后的净利润 | 36,171,475.1 | 63,752,438.02 | 65,567,787.86 | 55,949,765.99 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.35 | 0.83 | 0.63 | 0.49 |
| (二)稀释每股收益 | 0.35 | 0.83 | 0.63 | 0.49 |
| 八、其他综合收益 | -149,882.19 | 29,553,817.39 | 29,747,484.62 | 29,992,577.05 |
| 归属于母公司股东的其他综合收益 | -112,411.64 | 29,552,967.69 | 29,692,673.85 | 29,882,076.7 |
| 九、综合收益总额 | 69,033,798.88 | 179,549,567.97 | 140,615,970.85 | 115,540,837.12 |
| 归属于母公司股东的综合收益总额 | 69,626,400.02 | 180,255,514.91 | 140,514,412.58 | 115,218,991.06 |
| 归属于少数股东的综合收益总额 | -592,601.14 | -705,946.94 | 101,558.27 | 321,846.06 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-30 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |